We are excited to announce that we are actively enrolling in three new clinical trials!
This is a first come first serve opportunity to enroll in 3 new clinical trials; GLEAM, GLOW, and DAYLIGHT.
The GLEAM and GLOW protocols are for patients that have diabetic retinopathy.
The DAYLIGHT protocol is for patients with Neovascular Age Related Macular Degeneration.
Please see our research tab for more info. If you feel like you would like to participate in this amazing opportunity, please call us at (806)-351-1870.